Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Amortization of Deferred Charges (2023 - 2024)

Historic Amortization of Deferred Charges for 60 Degrees Pharmaceuticals (SXTP) over the last 2 years, with Q1 2024 value amounting to $125368.0.

  • 60 Degrees Pharmaceuticals' Amortization of Deferred Charges fell 6092.32% to $125368.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $173793.0, marking a year-over-year change of. This contributed to the annual value of $669148.0 for FY2023, which is 3863.21% down from last year.
  • As of Q1 2024, 60 Degrees Pharmaceuticals' Amortization of Deferred Charges stood at $125368.0, which was down 6092.32% from $23812.0 recorded in Q3 2023.
  • 60 Degrees Pharmaceuticals' 5-year Amortization of Deferred Charges high stood at $320825.0 for Q1 2023, and its period low was $23812.0 during Q3 2023.